5F36
Crystal structure of the bromodomain of human ATAD2 in complex with Compound A12
Summary for 5F36
Entry DOI | 10.2210/pdb5f36/pdb |
Descriptor | ATPase family AAA domain-containing protein 2, [(2~{R})-1-[(4-ethanoyl-1,3-thiazol-2-yl)amino]-1-oxidanylidene-propan-2-yl]azanium, SULFATE ION, ... (5 entities in total) |
Functional Keywords | hydrolase inhibitor complex, transferase |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 1 |
Total formula weight | 15799.29 |
Authors | Dong, J.,Caflisch, A. (deposition date: 2015-12-02, release date: 2016-12-14, Last modification date: 2024-01-10) |
Primary citation | Dolbois, A.,Batiste, L.,Wiedmer, L.,Dong, J.,Brutsch, M.,Huang, D.,Deerain, N.M.,Spiliotopoulos, D.,Cheng-Sanchez, I.,Laul, E.,Nevado, C.,Sledz, P.,Caflisch, A. Hitting a Moving Target: Simulation and Crystallography Study of ATAD2 Bromodomain Blockers. Acs Med.Chem.Lett., 11:1573-1580, 2020 Cited by PubMed: 32832026DOI: 10.1021/acsmedchemlett.0c00080 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.5 Å) |
Structure validation
Download full validation report